Our results showed that there was no difference in serum MBL level between anti-PLA2R(+) and anti-PLA2R(−)groups in patients with iMN; however, serum MBL levels were significantly higher in anti-PLA2R-positive groups than in negative groups in patients with aMN. The gene discussed is PLA2R1; the disease is adrenomyeloneuropathy.